EMA CHMP has recommended the following for approval: Fylrevy, Ilumira, Kayshild, Kygevvi, Supemtek & Rezurock.
Importance
Level 1
- Recommended an extension on Zynyz. Positive option to extend Eurneffy. and seven other extensions for: Akeega, Efmody, Iclusig, Imfinzi, Kerendia, Noxafil and Opdivo.
#FRANCE#EUROPE#SANOFI#SAN.FP#BANCO SANTANDER SA#EQUITIES#EU SESSION#PHARMACEUTICALS#DIVERSIFIED BANKS#PHARMACEUTICALS (GROUP)#BANKS#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#BANKS (GROUP)#SAN#EURO STOXX 50#CAC 40 INDEX#SANOFI SA#GLOBAL EQUITIES